Form 4 for AMGN Amgen
Accepted 2022-05-04 00:00:00 ET · period of report 2022-05-02 · accession 0001127602-22-013345 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-04 | 2022-05-03 | AMGN | Graham Jonathan P | EVP, Gen. Counsel, Secy | F - Tax | $230.92 | -566 | 51.4K | -1% | -$130.7K |
| D | 2022-05-04 | 2022-05-02 | AMGN | Graham Jonathan P | EVP, Gen. Counsel, Secy | A - Grant | $0.00 | +3,377 | 52.0K | +7% | $0 |
| D | 2022-05-04 | 2022-05-02 | AMGN | Graham Jonathan P | EVP, Gen. Counsel, Secy | A - Grant | $0.00 | +27.6K | 27.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-03 | F | D | 566 | $230.92 | 51,407 | D | — | — | (F3) These shares include 902 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. (F2) These shares include the following RSUs granted under the Company's equity plans: 1,074 RSUs which will vest in one installment of 1,074 on 5/3/2023; 6,148 RSUs which vest in one installment of 3,028 on 11/1/2022 and one installment of 3,120 on 11/1/2023; 3,300 RSUs which vest in two installments of 1,089 on 5/5/2022 and 5/5/2023 and one installment of 1,122 on 5/5/2024; 3,797 RSUs which vest in two installments of 1,253 on 4/30/2023 and 4/30/2024 and one installment of 1,291 on 4/30/2025; and 3,377 RSUs which vest in two installments of 1,114 on 5/2/2024 and 5/2/2025, and 1,149 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. |
| 2 | Common | Common Stock | 2022-05-02 | A | A | 3,377 | $0.00 | 51,973 | D | — | — | (F1) The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/2/2024, 5/2/2025 and 5/2/2026, respectively. |
| 3 | Derivative | Nqso (Right to Buy) | 2022-05-02 | A | A | 27,574 | $0.00 | 27,574 | D | $230.92 · 2024-05-02 to 2032-05-02 | 27,574 Common Stock | (F4) These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/2/2024, 5/2/2025 and 5/2/2026, respectively. |